Home - Products - Angiogenesis - c-Met/HGFR - C-Met inhibitor D9

C-Met inhibitor D9

CAS No. 299405-67-7

C-Met inhibitor D9( —— )

Catalog No. M36033 CAS No. 299405-67-7

C-Met inhibitor D9 is a c-Met kinase inhibitor.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	296	Get Quote
5MG	426	Get Quote
10MG	625	Get Quote
25MG	908	Get Quote
50MG	1270	Get Quote
100MG	1701	Get Quote
500MG	3402	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

C-Met inhibitor D9
Note

Research use only, not for human use.
Brief Description

C-Met inhibitor D9 is a c-Met kinase inhibitor.
Description

C-Met inhibitor D9 is a c-Met kinase inhibitor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

c-Met/HGFR
Recptor

c-Met/HGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

299405-67-7
Formula Weight

293.32
Molecular Formula

C17H15N3O2
Purity

>98% (HPLC)
Solubility

——
SMILES

N(NC(CCC1=CC=CC=C1)=O)=C2C=3C(NC2=O)=CC=CC3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

JNJ-38877618

JNJ-38877618 (OMO-1) is a novel potent, highly selective, orally bioavailable c-Met tyrosine kinase inhibitor.
palovarotene

Palovarotene is an agonist of nuclear retinoic acid receptor γ (RAR-γ).
TRX818

TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.

Sign In Join Free